Background & Aim: Multiple sclerosis (MS) is a relapsing or progressive neurological disease with an unknown etiology and only partially effective treatment. MS can have a negative impact on both physical ... took place…
Introduction: Multiple Sclerosis (MS) is a relapsing or progressive neurological disease with an unknown etiology. MS has a negative impact on both physical and psychological well-being ... Methods: The study took place…
course of Multiple Sclerosis (MS) is incredibly diverse. "Aggressive" disease is characterised by a relapsing history that rapidly worsens physical and cognitive dysfunction, frequently in spite of treatment…
with unrelenting effects on memory function. Moreover, it also shows that the relapsing-remitting form of multiple sclerosis might have underlying degenerative processes that are ongoing yet undetected. It raises…
results of high dose intravenous monthly pulse CYC on patients with worsening relapsing-remitting multiple sclerosis (RRMS) and secondary progressive multiple sclerosis (SPMS) were evaluated. Methods: Fifty-six patients…
cells. In the Phase III placebo-controlled trial in relapsing–remitting multiple sclerosis (the CLARITY study), oral cladribine at 96 weeks significantly reduced annual relapse rates by 54–57% compared
Progressive Multifocal Leukoencephalopathy (PML), developed after treatment with Natalizumab for 42 months for relapsing remitting multiple sclerosis (RRMS). Imaging was consistent with wide-spread PML with features…
Treatment with laquinimod ameliorated disease activity in experimental autoimmune encephalomyelitis, a mouse model for multiple sclerosis. In the past, an immunosuppressive mechanism of action was initially assumed…
choice of humanized monoclonal antibody is a novel therapeutic approach for autoimmune relapsing remitting multiple sclerosis (RRMS). In addition to anti-alpha-4 integr in monoclonal antibody Natalizumab, introduction
rates in MS patients than the general population. Methods: Subjects consisted of 72 relapsing remitting multiple sclerosis patients and 57 controls. Demographic characteristics including age, gender, education level…
mutations of mitochondrial DNA. Mitochondrial genetic variations may influence susceptibility to develop multiple sclerosis and neuromyelitis optica. In order to explore the possible correlation between mitochondrial…
during the next pregnancy after abortion. Interferon beta-1a for the treatment of relapsing-remitting multiple sclerosis was stopped before pregnancy. During pregnancy only subcutaneous immunoglobulin was administered…
patient suffered acute myelitis. Our patient represents a rare case of late onset Relapsing-Remitting Multiple Sclerosis (RRMS) presenting with an eight-and-a-half-syndrome. Apart from the clinical
Herein, we present a case of a 39-year-old female patient with relapsing-remitting multiple sclerosis (MS), who was receiving immunomodulatory therapy and subsequently developed severe PAH. We presume
Background: Multiple sclerosis is a chronic inflammatory disorder of the central nervous system. This study aimed to assess the association between the serum level of chloride intracellular channel 1 (CLIC1 ... ducted a…
Background: It is known that multiple sclerosis affects both sexes differently. Females suffer from this condition twice as more than males. The most common symptom, reported by patients is chronic ... participants, 18…
Background: T-cell vaccination (TCV) for multiple sclerosis (MS) refers to treatment with autologous anti-myelin T-cells, attenuated by irradiation. Aim: In order to test anti-MSP autoimmunity ... clinical outcome of…
clinical reasoning process in an inpatient rehabilitation center. Four patients suffered from Multiple Sclerosis (MS) Relapsing Remitting MS (RRMS), Primary Progressive MS (PPMS) and Secondary Progressive MS (SPMS
probiotics supplementation on disease progression, depression, general health, and anthropometric measurements in relapsing-remitting multiple sclerosis patients: A systematic review and meta-analysis of clinical…
analytical methods. Copaxone,Ã?® a synthetic polypeptide mixture, used for the treatment of Relapsing Remitting Multiple Sclerosis, is one such NBCD. For the past 9 years Teva has invested considerable
clinical presentations of MS. ? Understand the current treatment strategies for MS. Define terms: ? Multiple Sclerosis (MS) ? Relapse ? Relapsing Remitting MS ? Secondary Progressive MS ? Primary Progressive MS ?…
inhibited experimental autoimmune encephalomyelitis mediated by functional FoxA1 and PDL1. In patients with relapsing-remitting multiple sclerosis, response to IFN-β-treatment was associated with expansion of…
Background: Multiple sclerosis (MS) is an immunemediated inflammatory disease that attacks myelinated axons in the central nervous system leading to significant disability. Worldwide, approximately 2.1 million peoples…